131 related articles for article (PubMed ID: 1872309)
1. Rationale for the association of sulfonylurea and insulin.
Del Prato S
Am J Med; 1991 Jun; 90(6A):77S-82S. PubMed ID: 1872309
[TBL] [Abstract][Full Text] [Related]
2. Type II diabetic subjects with secondary failure: treatment with prebreakfast mixed ultralente and regular insulin with a sulfonylurea.
Kabadi UM; Kabadi MU
J Fam Pract; 1991 Oct; 33(4):349-53. PubMed ID: 1919450
[TBL] [Abstract][Full Text] [Related]
3. Combined insulin-sulfonylurea therapy in treatment of NIDDM.
Groop LC; Groop PH; Stenman S
Diabetes Care; 1990 Aug; 13 Suppl 3():47-52. PubMed ID: 2209344
[TBL] [Abstract][Full Text] [Related]
4. Hepatic sensitivity to insulin: effects of sulfonylurea drugs.
Del Prato S; Vigili de Kreutzenberg S; Riccio A; Tiengo A
Am J Med; 1991 Jun; 90(6A):29S-36S. PubMed ID: 1872301
[TBL] [Abstract][Full Text] [Related]
5. Combination insulin-sulfonylurea therapy.
Lebovitz HE; Pasmantier R
Diabetes Care; 1990 Jun; 13(6):667-75. PubMed ID: 2192850
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of sulfonylureas with insulin in type 2 diabetes mellitus.
Kabadi MU; Kabadi UM
Ann Pharmacother; 2003 Nov; 37(11):1572-6. PubMed ID: 14565810
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of insulin and sulfonylurea combination therapy in type II diabetes. A meta-analysis of the randomized placebo-controlled trials.
Johnson JL; Wolf SL; Kabadi UM
Arch Intern Med; 1996 Feb; 156(3):259-64. PubMed ID: 8572835
[TBL] [Abstract][Full Text] [Related]
8. Acute and chronic effects of sulfonylurea drugs on pancreatic islet function in man.
Pfeifer MA; Halter JB; Judzewitsch RG; Beard JC; Best JD; Ward WK; Porte D
Diabetes Care; 1984; 7 Suppl 1():25-34. PubMed ID: 6376026
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms for hyperglycemia in type II diabetes mellitus: therapeutic implications for sulfonylurea treatment--an update.
Porte D; Kahn SE
Am J Med; 1991 Jun; 90(6A):8S-14S. PubMed ID: 1872310
[TBL] [Abstract][Full Text] [Related]
10. Modification of postprandial hyperglycemia with insulin lispro improves glucose control in patients with type 2 diabetes.
Feinglos MN; Thacker CH; English J; Bethel MA; Lane JD
Diabetes Care; 1997 Oct; 20(10):1539-42. PubMed ID: 9314631
[TBL] [Abstract][Full Text] [Related]
11. Combined therapy with a sulfonylurea plus evening insulin: safe, reliable, and becoming routine.
Riddle MC
Horm Metab Res; 1996 Sep; 28(9):430-3. PubMed ID: 8911978
[TBL] [Abstract][Full Text] [Related]
12. Treatment of non-insulin-dependent diabetes mellitus with metformin.
Guthrie R
J Am Board Fam Pract; 1997; 10(3):213-21. PubMed ID: 9159660
[TBL] [Abstract][Full Text] [Related]
13. Insulin: either alone or combined with oral hypoglycemic agents.
Firth RG
Prim Care; 1988 Sep; 15(3):665-83. PubMed ID: 3054969
[TBL] [Abstract][Full Text] [Related]
14. Are oral hypoglycemic agents likely to benefit NIDDM patients? Affirmative.
Lebovitz HE
Hosp Pract (Off Ed); 1992 Feb; 27 Suppl 1():26-31; discussion 35-6. PubMed ID: 1347536
[TBL] [Abstract][Full Text] [Related]
15. Treatment of NIDDM with insulin agonists or substitutes.
Galloway JA
Diabetes Care; 1990 Dec; 13(12):1209-39. PubMed ID: 1980453
[TBL] [Abstract][Full Text] [Related]
16. Oral antidiabetic agents. The emergence of alpha-glucosidase inhibitors.
Lebovitz HE
Drugs; 1992; 44 Suppl 3():21-8. PubMed ID: 1280574
[TBL] [Abstract][Full Text] [Related]
17. [The effectiveness of combined insulin and sulfonylurea in treating non-insulin dependent diabetic patients].
Sun Y; Xiong Y; Yang J
Zhonghua Nei Ke Za Zhi; 1995 Apr; 34(4):246-9. PubMed ID: 7587604
[TBL] [Abstract][Full Text] [Related]
18. Treatment strategies for secondary sulfonylurea failure. Should we start insulin or add metformin? Is there a place for intermittent insulin therapy?
Groop L; Widén E
Diabete Metab; 1991 May; 17(1 Pt 2):218-23. PubMed ID: 1936480
[TBL] [Abstract][Full Text] [Related]
19. The clinical use of oral sulfonylureas in the management of non-insulin dependent diabetes mellitus (NIDDM).
Ponte CD
W V Med J; 1990 Oct; 86(10):455-8. PubMed ID: 2238629
[TBL] [Abstract][Full Text] [Related]
20. [Short-term intensive insulin therapy as a method of overcoming secondary failure of sulfonylureas in patients with type 2 diabetes (non-insulin-dependent)].
Jedynasty K; Kasperska-Czyzykowa T; Stepień K; Nowaczyk R
Pol Arch Med Wewn; 1998 Jun; 99(6):442-51. PubMed ID: 10085698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
